CollPlant Reports Q2 2026 Results and Acquires LightSolver to Expand into Photonic Computing

Key Facts

1CollPlant Biotechnologies announced its financial results for the second quarter of 2026 and provided a corporate update.

2The company revealed a strategic expansion into photonic computing via the acquisition of LightSolver.

CollPlant Biotechnologies announced its financial results for the second quarter of 2026, reporting a GAAP net loss of $2.7 million, or $1.89 per basic share. The company stated in a PR Newswire release that this compares to a net loss of $3.3 million in the second quarter of 2025. Alongside the financial update, the company revealed a strategic expansion into photonic computing through the acquisition of LightSolver.

CLGN closed at $3.79 on September 29, 2026, with the stock trading between a high of $3.94 and a low of $3.68 during that session. The diversification into photonic computing aims to complement the company's existing innovations in regenerative medicine, supported by a cost reduction plan that lowered personnel expenses and research and development costs.